China Health Group Inc. (HKG:8225)

Hong Kong · Delayed Price · Currency is HKD

0.0600

0.00 (0.00%)

At close: Nov 10, 2026

Market Cap	59.72M -59.2%
Revenue (ttm)	34.52M +0.4%
Net Income	-16.35M
EPS	-0.02
Shares Out	995.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0600
Day's Range	n/a
52-Week Range	0.0600 - 0.1600
Beta	-0.35
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About China Health Group

China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People’s Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1998

Employees 33

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 8225

Full Company Profile

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY Financial Statements